Skip to content
About Prolight
Market
Partnerships
Board of Directors and Management
Clinical Advisory Board
History
Cutting-edge technology
Vision & strategy
Products
Psyros™
MicroFlex
Patents
Investors
Press releases
Financial reports
CEO comment
Financial calendar
Stock information
AGM
Shareholders
Key figures
Corporate governance
Prospectus
Media
Press releases
Investor letters
Media gallery
Presentations
Articles
Contact us
About Prolight
Market
Partnerships
Board of Directors and Management
Clinical Advisory Board
History
Cutting-edge technology
Vision & strategy
Products
Psyros™
MicroFlex
Patents
Investors
Press releases
Financial reports
CEO comment
Financial calendar
Stock information
AGM
Shareholders
Key figures
Corporate governance
Prospectus
Media
Press releases
Investor letters
Media gallery
Presentations
Articles
Contact us
EN
SV
Press releases
Category
All
Regulatory
Non-Regulatory
Interim
Annual
Year
All
2025
2024
2023
2022
2024
2024-05-17 08:15
Prolight Diagnostics publishes quarterly report Q1, 2024
Regulatory
MAR
2024-05-17 08:00
Prolight Diagnostics awarded SEK17M UK government grant in collaboration with leading UK hospital Trust
2024-05-16 20:35
The exercise price for the warrants of series TO6 in Prolight Diagnostics has been determined to SEK 0.10 per share
Regulatory
2024-05-02 08:00
Prolight selects MDx CRO for the clinical performance studies for Psyros™
Regulatory
2024-04-30 11:20
Prolight Diagnostics AB (publ) publishes annual report for 2023
Regulatory
2024-04-25 14:55
NOTICE OF THE ANNUAL GENERAL MEETING IN PROLIGHT DIAGNOSTICS AB (PUBL)
Regulatory
2024-04-25 10:30
Emergers publishes updated analysis about Prolight Diagnostics
2024-04-24 08:00
Prolight finalizes commercial cartridge design
2024-04-22 19:10
Prolight writes down capitalized development costs for MicroFlex and delays publication of the annual report
Regulatory
2024-04-18 08:00
Prolight announces positive accounting adjustments for the full year 2023
Regulatory
MAR
Previous
Next